AXL receptor tyrosine kinase as a therapeutic target in NSCLC

The AXL receptor tyrosine kinase and its ligand, Gas6, regulate key processes in lung cancer growth, metastasis, and epithelial–mesenchymal transition-associated drug resistance. Gas6 and AXL expression have been correlated with poor prognosis and advanced clinical stage in patients with lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Okimoto, Ross A, Bivona, Trever G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217513/
https://www.ncbi.nlm.nih.gov/pubmed/28210148
http://dx.doi.org/10.2147/LCTT.S60438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217513/
https://www.ncbi.nlm.nih.gov/pubmed/28210148
http://dx.doi.org/10.2147/LCTT.S60438

Ejemplares similares